All Ebola virus articles
-
NewsLong Ebola: Sudan virus can persist in survivors for months, study shows
More than half of survivors of the Sudan Ebola virus still suffer serious health problems two years post-infection and the virus can persist in semen and breast milk for months after recovery, according to the first study examining the virus’s long-term effects.
-
NewsBeyond health: The political effects of infectious disease outbreaks
A new study gives empirical evidence that individuals who experienced an infectious disease outbreak show significantly less trust in the political establishment.
-
NewsScientists zoom in on structure of still lethal Ebola virus
The first high-resolution visualisation of the Ebola virus nucleocapsid provides detailed insights into the interactions within the nucleocapsid complex, unveiling the relationship between molecular interactions and functional regulation.
-
NewsPromising antibody may prove useful against deadly Ebola virus outbreaks
New research reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus therapeutics.
-
NewsThe hunt narrows for Ebola virus hosts
A cholesterol-trafficking receptor, Niemann-Pick C1 (NPC1), was identified for more efficient surveillance of host reservoirs of filoviruses, including Ebolaviruses. It narrows down the host species of the virus and links to the geographic information of pathogen emergence.
-
NewsScientists advance nanobody technology to combat deadly Ebola virus
Researchers have developed the first nanobody-based inhibitors targeting the Ebola virus. Their small size allows them to access areas of the virus and human tissues that larger antibodies cannot.
-
NewsStudy traces Ebola’s route to the skin surface
Researchers have traced a cellular route the Ebola virus uses to traverse the inner and outer layers of skin and emerge onto the skin’s surface. The study identifies new cell types within the skin that are targeted by EBOV during infection.
-
NewsA new class of antivirals could help prevent future pandemics
A new study introduces a proof-of-concept for a novel class of antivirals that would target a type of enzyme essential not just to SARS, but also many RNA viruses, including Ebola and dengue, as well as cytosolic-replicating DNA viruses, including Pox viruses.
-
NewsExperts develop laboratory toolkit for patients with viral hemorrhagic fevers such as Marburg virus disease
New resource provides guidance for healthcare facilities to perform basic laboratory testing in a safe and effective manner for patients at risk for Viral Hemorrhagic Fevers.
-
![Ebola[2]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/3/4/1/9341_ebola2_867385_crop.jpg)
NewsDiscovery paves the way for antivirals against Ebola virus and its deadly relatives
The first detailed, complete images of the Ebola virus nucleocapsid may accelerate the development of antivirals to combat several filoviruses at once.
-
NewsEffective health comms needed to save lives during epidemics
An African infectious disease expert discusses how effective public health communication is critical for fighting epidemics and saving lives across the African continent.
-
NewsMore than half of global infectious diseases experts surveyed rate influenza as the number one pathogen of concern of pandemic potential
When infectious diseases experts were asked to rank pathogens in order of their pandemic potential, influenza was considered the pathogen of highest pandemic risk, with 57% ranking it as number one, and 17% ranking it second.
-
NewsScientists discover Ebola virus uses tunnelling nanotubes to infect cells
A new study indicates that Ebola virus creates and uses intercellular tunnels to move from cell to cell within the human body and evade treatments.
-
NewsScientists reveal inner workings of Ebola’s ‘viral factories’
A new study reveals how the Ebola virus’s replication machinery forms fascinating microscopic structures inside host cells that become viral factories.
-
NewsMechanisms may be used to lure viruses into a trap
Researchers have described previously unknown mechanisms of viral penetration by the Influenza A and Ebola viruses, which could lead to new approaches to prevent infections.